Effect of punicalagin on multiple targets in streptozotocin/high-fat diet-induced diabetic mice.

Food & Function
Dan JinBenhong Zhou

Abstract

Type 2 diabetes has a series of metabolic aberrations accompanied by chronic hyperglycemia, along with various comorbidities. In recent reports, punicalagin from pomegranate has been reported to exert hypoglycemic effects against diabetes. The goal of the current research was to investigate the therapeutic effectiveness and elucidate the mechanisms of punicalagin underlying type 2 diabetes. Type 2 diabetes was induced by a high-fat diet (HFD) combined with streptozotocin (STZ) injection in C57BL/6J mice. Punicalagin was administered daily by oral gavage for 4 weeks. The results indicated that high FBG (fasting blood glucose), dyslipidemia and associated islet, liver and kidney injury were observed in the model group mice. Through metabolomics analysis, it was found that the administration of punicalagin could regulate 24 potential biomarkers and their related metabolic pathways. Moreover, the pathological changes in the liver and kidney were mainly mediated by reducing gluconeogenesis and increasing glycogenesis via stimulation of the PI3K/AKT signaling pathway and regulation of the HMGB-1/TLR4/NF-κB signaling pathway, which simultaneously interrelated to ten main pathological pathways. In addition, we confirmed the positive ro...Continue Reading

References

Jun 17, 1998·Metabolism: Clinical and Experimental·J LuoG M Reaven
Oct 5, 2001·Nature Reviews. Molecular Cell Biology·P Cohen, S Frame
Oct 3, 2002·Nature Reviews. Immunology·Qiutang Li, Inder M Verma
Nov 15, 2002·Trends in Endocrinology and Metabolism : TEM·Eileen L WhitemanMorris J Birnbaum
Feb 21, 2003·European Journal of Nutrition·Begoña CerdáFrancisco A Tomás-Barberán
May 15, 2003·Journal of Agricultural and Food Chemistry·Begoña CerdáJuan Carlos Espín
May 27, 2004·Diabetes Care·Ronald M Krauss
Sep 17, 2004·Genes & Development·Matthew S Hayden, Sankar Ghosh
Jun 28, 2005·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·K SrinivasanP Ramarao
Feb 8, 2006·Annual Review of Physiology·Sudha B Biddinger, C Ronald Kahn
Dec 28, 2006·Physiological Genomics·R M SalekJ L Griffin
May 5, 2007·Diabetes Research and Clinical Practice·Jongsoon Lee, Myung-Sunny Kim
Jul 27, 2007·Journal of Medicinal Food·Sarah Rachel KatzEphraim Philip Lansky
Nov 22, 2007·Trends in Molecular Medicine·Taro Kawai, Shizuo Akira
Jan 11, 2008·Annual Review of Pharmacology and Toxicology·Rima Kaddurah-DaoukRichard M Weinshilboum
Sep 15, 2010·Molecular Aspects of Medicine·Mar LarrosaFrancisco A Tomás-Barberán
Oct 19, 2010·Archives of Toxicology·Mamas MamasRoyston Goodacre
Mar 23, 2011·Nature Medicine·Thomas J WangRobert E Gerszten
May 4, 2011·Nature Reviews. Nephrology·Juan F Navarro-GonzálezJavier García-Pérez
Jul 29, 2011·Critical Reviews in Food Science and Nutrition·Ana Faria, Conceição Calhau
Feb 14, 2012·Aging·Dongsheng Cai, Tiewen Liu
Jan 15, 2013·Cell Metabolism·Christian Rask-Madsen, George L King
Jul 20, 2014·Trends in Biochemical Sciences·Krushna C Patra, Nissim Hay
Aug 27, 2014·Journal of Food Science·Kayoko KawakamiHideyuki Ito
Nov 21, 2014·Journal of Diabetes Investigation·Søs Skovsø
Dec 30, 2014·Toxicology and Applied Pharmacology·Kahkashan Rashid, Parames C Sil
Apr 25, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H-H ChenP-H Kuo
Nov 26, 2015·Science Advances·Yuanyuan FengXiangmei Chen
Nov 26, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Preeti Kanikarla-Marie, Sushil K Jain
Mar 12, 2016·Nature Reviews. Drug Discovery·David S Wishart

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
Protein Assay
electrophoresis
PCR
PCA

Software Mentioned

OPLS
OmicsBean
Excel
SIMCA
DA
Metabolomics
AlphaEaseFC
Statistical Package for the Social Sciences

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Related Papers

The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology
Yujue WangJie Mei
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Jun Seob ShinDong-Seok Kim
© 2021 Meta ULC. All rights reserved